Search Back New search Go to resultsDiseaseMain groupCross-Sectional, Transplantation, Cellular TherapySolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyVisceral SurgeryDiseaseColon CancerEsophageal CancerGastric CancerPeritoneal Carcinomatosis, SecondarySubgroupAdenocarcinoma of the esophagogastric junction (AEG)ICD10C15.-C16.-C16.0C18.0C18.2C18.3C18.4C18.5C18.6C18.7C18.8C19C78.6MeSHColorectal NeoplasmsEsophageal NeoplasmsPeritoneal NeoplasmsStomach NeoplasmsSequenceChemotherapyChemo-substanceCisplatinFluorouracilChemo-substanceCisplatinFluorouracilChemo-substanceCisplatinFluorouracilChemo-substanceCisplatinFluorouracilNo. Substances1 RadiotherapySupportive therapySupportive substanceDexamethasoneFilgrastimFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceDexamethasoneFilgrastimFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceDexamethasoneFilgrastimFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateSupportive substanceDexamethasoneFilgrastimFosaprepitantGranisetronNaCl 0.9%Sodium ThiosulfateNo. Substances35Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationTherapy phaseintraoperativTherapy intentioncurativepalliativeRisksEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorGhanipour LGötze TDiseaseLokalisiertes oder lokal fortgeschrittenes Magen-Ca oder Karzinom des gastroösopagealen Übergangs Typ II/IIIPeritonealkarzinose, sekundärOriginPREVENT - FLOT9 trial of the AIO / CAOGI / ACOUppsala University, Uppsala, SwedenProtocols in Revision 2 protocols foundProtocols under revision.EPIC - Fluorouracil 400, Peritoneal Carcinomatosis, Secondary (PID2709 V1.0)HIPEC - Cisplatin 75, Adenocarcinoma Esophagogastric Junction and Stomach (PID2710 V1.1)
